Page last updated: 2024-12-07

isouramil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

isouramil: aglycone of convicine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID77518
SCHEMBL ID11069007
SCHEMBL ID2236804
MeSH IDM0100639

Synonyms (17)

Synonym
2,4(1h,3h)-pyrimidinedione, 6-amino-5-hydroxy-
5,6-dihydroxycytosine
6-amino-2,4,5-trihydroxypyrimidine
isouramil
AKOS006347193
3914-34-9
6-amino-5-hydroxy-1h-pyrimidine-2,4-dione
SCHEMBL11069007
SCHEMBL2236804
DTXSID90192387
6-amino-5-hydroxyuracil
Z2465619900
2,4(1h,3h)-pyrimidinedione, 6-amino-5-hydroxy- (9ci)
6-aminopyrimidine-2,4,5-triol
6-amino-5-hydroxy-1,2,3,4-tetrahydropyrimidine-2,4-dione
SB57155
EN300-263554

Research Excerpts

Treatment

ExcerptReferenceRelevance
"When treated with isouramil, after a fall in the first few minutes, the GSH level was completely regenerated after 20 min."( Effect of factors of favism on the protein and lipid components of rat erythrocyte membrane.
D'Aquino, M; Gaetani, S; Spadoni, MA, 1983
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (63.16)18.7374
1990's4 (21.05)18.2507
2000's1 (5.26)29.6817
2010's2 (10.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]